内镜下套扎术治疗内痔54例前瞻性研究

目的研究微创治疗内痔新方法内镜下套扎术治疗内痔的疗效及安全性。方法收集2017年2月-2018年2月于该院行内镜下套扎术治疗的54例Ⅱ至Ⅲ期内痔患者,随访1、6和12个月,观察患者症状改善情况、并发症发生及复发情况,应用疼痛评分、出血评分、生活质量评分和脱出程度评分来评估内镜下套扎术的疗效及安全性。结果术后随访12个月,47例治疗有效,治疗有效率87.0%,均未出现严重并发症,进行疼痛视觉模拟评分(VAS)、出血评分、生活质量及脱出程度评分,对比治疗前后,各个指标均有明显下降,VAS评分由(3.9±2.1)分降至(1.9±1.1)分(P=0.012),出血评分由(5.5±2.4)分降至(2.3±1.5)分(P=0.000),生活质量评分由(2.6±0.7)分降至(1.2±0.6)分(P=0.039),脱出程度评分由(2.4±0.5)分降至(1.6±0.6)分(P=0.002),2例(3.7%)患者出现复发,分别发生于10和11个月。结论内镜下套扎术治疗内痔临床疗效确切,是一种安全有效的治疗方法。

Endoscopic ligation for hemorrhoidal disease: prospective results in 54 patients

Abstract: Objective?To evaluate the efficacy and safety of endoscopic ligation for hemorrhoidal disease as a first-line invasive treatment.?Methods?This prospective study was conducted from Feburary 2017 to Feburary 2018 on 54 consecutive patients with grade II-III hemorrhoids. Endoscopic ligation was performed. Over the following 1 month, 6 months, 12 months, the improvement of symptoms, occurrence of complications and recurrence were observed. Clinical outcomes were evaluated using the visual analog scale (VAS) score for pain, French bleeding score, quality-of-life score and prolapse score.?Results?At 12 months after ligation, clinical success was obtained in 47 patients (87.0%), no patients experienced any serious complications.all indexes evaluated were decline significantly. VAS score decreased from (3.9?±?2.1) to (1.9?±?1.1) (P?=?0.012), and bleeding score decreased from (5.5?±?2.4) to (2.3?±?1.5) (P?=?0.000). Quality-of-life score decreased from (2.6?±?0.7) to (1.2?±?0.6) (P?=?0.039) and prolapse scores decreased from (2.4?±?0.5) to (1.6?±?0.6) (P?=?0.002), and recurrence were observed in 2 patients (3.7%), occurred after 10 and 11 month.?Conclusions?Endoscopic ligation was found to be a safe and effective treatment for hemorrhoids.